相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
请参考说明书
- 亚型:
请参考说明书
- 形态:
液体
- 保存条件:
Aliquot and store at -20ºC
- 克隆性:
请参考说明书
- 标记物:
请参考说明书
- 适应物种:
human/mouse/rat等
- 宿主:
rabbit/mouse
- 应用范围:
ELISA,WB,IHC等
- 浓度:
请参考说明书
- 靶点:
请参考说明书
- 抗体英文名:
cysteine dioxygenase antibody
- 抗体名:
cysteine dioxygenase antibody
- 规格:
100μl
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验How Do I make an Antibody against a Peptides
If your peptide is synthesized with a terminal cysteine residue (i.e., a free sulfhydryl group, -SH), you can use any maleimide-activated carrier protein to create an immunogen. One-step chemical reactions are easy with Pierce Sulfo-SMCC Pre
make an Antibody against a Peptides
make an Antibody against a Peptides If your peptide is synthesized with a terminal cysteine residue (i.e., a free sulfhydryl group, -SH), you can use any maleimide-activated carrier protein
PEGylation of Antibody Fragments to Improve Pharmacodynamics and Pharmacokinetics
Covalent attachment of polyethylene glycol (PEG) with therapeutic proteins (PEGylation) e.g., antibodies, antibody fragments, and enzymes, has been emerged as an effective strategy to enhance the pharmacodynamics and pharmacological
技术资料暂无技术资料 索取技术资料





![PSMD4 antibody [N1C2]](https://img1.dxycdn.com/2023/0711/255/2344116916935858761-14.jpg!wh200)
![C4d antibody [10-11]](https://img1.dxycdn.com/2023/0711/451/6106825198874858761-14.jpg!wh200)
![Grp78 antibody [C2C3], C-term](https://img1.dxycdn.com/2023/0516/895/8887749495766728561-14.jpg!wh200)

